Gene · 970
Papers4,349
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,021 to 1,040 of 4,349
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| An update on epigenetic regulation in autoimmune diseases. | J Transl Autoimmun | 2022 | 36544624 | PubTator, text mining | PubMed |
| A modified hydrogel production protocol to decrease cellular content. | Acta Cir Bras | 2022 | 36542042 | PubTator, text mining | PubMed |
| Delineation of T cell subsets in chronic rhinosinusitis with nasal polyps. | Acta Otorhinolaryngol Ital | 2022 | 36541382 | PubTator, text mining | PubMed |
| CAR-T cell Therapies for B-cell Lymphoid Malignancies: Identifying Targets Beyond CD19. | Hematol Oncol Stem Cell Ther | 2022 | 36537906 | PubTator, text mining | PubMed |
| Single-cell transcriptomic analysis reveals differential cell subpopulations and distinct phenotype transition in normal and dissected ascending aorta. | Mol Med | 2022 | 36536281 | PubTator, text mining | PubMed |
| Insights into the role of long non-coding RNAs in DNA methylation mediated transcriptional regulation. | Front Mol Biosci | 2022 | 36533073 | PubTator, text mining | PubMed |
| Immune landscape-based machine-learning-assisted subclassification, prognosis, and immunotherapy prediction for glioblastoma. | Front Immunol | 2022 | 36532035 | PubTator, text mining | PubMed |
| Novel insight into miRNA biology and its role in the pathogenesis of systemic lupus erythematosus. | Front Immunol | 2022 | 36532020 | PubTator, text mining | PubMed |
| Lung cancer patients with chronic obstructive pulmonary disease benefit from anti-PD-1/PD-L1 therapy. | Front Immunol | 2022 | 36532019 | PubTator, text mining | PubMed |
| Membrane protein trafficking in the anti-tumor immune response: work of endosomal-lysosomal system. | Cancer Cell Int | 2022 | 36528587 | PubTator, text mining | PubMed |
| Machine learning-based identification of SOX10 as an immune regulator of macrophage in gliomas. | Front Immunol | 2022 | 36524115 | PubTator, text mining | PubMed |
| Chimeric antigen receptor T-cell therapy for T-ALL and AML. | Front Oncol | 2022 | 36523990 | PubTator, text mining | PubMed |
| A pan-cancer analysis of the oncogenic role of ribonucleotide reductase subunit M2 in human tumors. | PeerJ | 2022 | 36518297 | PubTator, text mining | PubMed |
| The expression pattern of pyroptosis-related genes predicts the prognosis and drug response of melanoma. | Sci Rep | 2022 | 36513682 | PubTator, text mining | PubMed |
| Spatial transcriptomics landscape of lesions from non-communicable inflammatory skin diseases. | Nat Commun | 2022 | 36513651 | PubTator, text mining | PubMed |
| FAM3D as a Prognostic Indicator of Head and Neck Squamous Cell Carcinoma Is Associated with Immune Infiltration. | Comput Math Methods Med | 2022 | 36510584 | PubTator, text mining | PubMed |
| Clinical potential of PD-1/PD-L1 blockade therapy for renal cell carcinoma (RCC): a rapidly evolving strategy. | Cancer Cell Int | 2022 | 36510217 | PubTator, text mining | PubMed |
| The role of CAR-T cell therapy as second line in diffuse large B-cell lymphoma. | Ther Adv Hematol | 2022 | 36505886 | PubTator, text mining | PubMed |
| The pro-invasive factor COL6A2 serves as a novel prognostic marker of glioma. | Front Oncol | 2022 | 36505882 | PubTator, text mining | PubMed |
| Comprehensive analysis of anoikis-related long non-coding RNA immune infiltration in patients with bladder cancer and immunotherapy. | Front Immunol | 2022 | 36505486 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/970/papers?page=52